Adam Mostafa

Track

Insider profile

Currently holds a position at X4 Pharmaceuticals Inc

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -38% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Treasurer, Assistant Secretary X4 Pharmaceuticals Inc March 13, 2019 -
Adam Mostafa's trades of X4 Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
482.63
Quantity 78,970 -48.9%
Value US$3,012,349
Transaction date
Proposed sale
Price
329.03
Quantity 50,968
Value US$3,903,161
Transaction date
Proposed sale
Price
0.64
Quantity 230,645
Value US$146,829
Transaction date
Proposed sale
Price
0.90
Quantity 52,500
Value US$47,250
Transaction date
Proposed sale
Price
0.97
Quantity 27,721
Value US$26,889
Transaction date
Proposed sale
Price
0.79
Quantity 230,645
Value US$182,463
Transaction date
Proposed sale
Price
1.96
Quantity 5,417
Value US$10,617
Transaction date
Proposed sale
Price
2.22
Quantity 5,417
Value US$12,051
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-27 2025-01-24
PlS Planned sale
78,970 -48.9%
482.63
US$3,012,349 		78,970 -48.9% 482.63 US$3,012,349
2025-01-24 2024-10-07
PrS Proposed sale
50,968
329.03
US$3,903,161 		50,968 329.03 US$3,903,161
2024-10-08 2024-10-07
PlS Planned sale
87,318 -41.7%
339.29
US$4,193,683 		87,318 -41.7% 339.29 US$4,193,683
2024-10-07 2024-10-07
PrS Proposed sale
230,645
0.64
US$146,829 		230,645 0.64 US$146,829
2024-03-11 2024-03-11
PrS Proposed sale
52,500
0.90
US$47,250 		52,500 0.90 US$47,250
2024-03-11 2024-03-11
S Sale
52,500 -100.0%
0.88
US$46,347 		52,500 -100.0% 0.88 US$46,347
2024-02-12 2024-02-12
PrS Proposed sale
27,721
0.97
US$26,889 		27,721 0.97 US$26,889
2024-02-12 2024-02-12
PlS Planned sale
27,721 -34.6%
1.01
US$27,973 		27,721 -34.6% 1.01 US$27,973
2023-11-03 2023-11-01
PlS Planned sale
230,645 -74.2%
0.73
US$168,371 		230,645 -74.2% 0.73 US$168,371
2023-11-01 2023-11-01
PrS Proposed sale
230,645
0.79
US$182,463 		230,645 0.79 US$182,463
2023-07-05 2023-06-30
PlS Planned sale
2,641 -3.2%
1.89
US$4,991 		2,641 -3.2% 1.89 US$4,991
2023-06-26 2023-06-23
PlS Planned sale
5,417 -6.1%
1.93
US$10,455 		5,417 -6.1% 1.93 US$10,455
2023-06-23 2023-06-23
PrS Proposed sale
5,417
1.96
US$10,617 		5,417 1.96 US$10,617
2023-06-16 2023-06-15
PlS Planned sale
5,417 -5.8%
2.22
US$12,026 		5,417 -5.8% 2.22 US$12,026
2023-06-15 2023-06-15
PrS Proposed sale
5,417
2.22
US$12,051 		5,417 2.22 US$12,051
2023-03-13 2023-03-10
PlS Planned sale
52,500 -35.9%
0.84
US$44,100 		52,500 -35.9% 0.84 US$44,100
2023-02-15 2023-02-13
PlS Planned sale
27,721 -15.9%
0.93
US$25,781 		27,721 -15.9% 0.93 US$25,781
2022-08-19 2022-08-17
PlS Planned sale
10,834
0.00
US$0 		10,834 0.00 US$0
2022-07-01 2022-06-30
PlS Planned sale
2,641
0.00
US$0 		2,641 0.00 US$0
2022-06-27 2022-06-24
PlS Planned sale
5,416
0.00
US$0 		5,416 0.00 US$0
2022-06-17 2022-06-16
PlS Planned sale
5,416
0.00
US$0 		5,416 0.00 US$0
2022-02-14 2022-02-11
PlS Planned sale
27,721
0.00
US$0 		27,721 0.00 US$0
2020-09-22 2020-09-21
PlS Planned sale
10,834 -26.8%
7.08
US$76,705 		10,834 -26.8% 7.08 US$76,705
2020-07-01 2020-06-30
PlS Planned sale
1,725 -16.3%
9.04
US$15,594 		1,725 -16.3% 9.04 US$15,594